FDA to appeal Utah ephedra ruling
The FDA will appeal to the United States Court of Appeal for the Tenth Circuit over the Utah court ruling that the FDA had failed to meet its burden of proof that a daily dose of 10 mg or less of ephedrine alkaloids presents an unreasonable risk of...